Gene expression analyses comparing aggressive cancer cells with high ZEB1 levels of different entities (breast, pancreas, colon) and corresponding ZEB1 knockdown cells revealed a strong reprogramming with expression changes (>3-fold up or down) in thousands of genes. This evidence concerns the gene ZEB1 and cancer.